InvestorsHub Logo
Followers 4
Posts 1242
Boards Moderated 0
Alias Born 01/16/2016

Re: None

Tuesday, 08/16/2016 7:02:33 PM

Tuesday, August 16, 2016 7:02:33 PM

Post# of 6602
On Talos: [continued "top level support" for the programme.]

http://www.janes.com/article/60916/ussocom-continues-to-advance-talos-development

Ekso is involved with TALOS:

RICHMOND, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced that their leading work on the first phase of the TALOS project resulted in a grant to expand their involvement into the second phase of the project. United States Special Operation Command (SOCOM) announced last year that it was working to create a wearable uniform, which provides superhuman capabilities with superior mobility and protection, for their Special Operations Forces. This project involves four phases, with the second phase to be delivered in the latter part of 2015. With the second phase of the project, this contract marks over $35 million in total third party funded development work done by the Ekso Bionics engineering team.

http://ir.eksobionics.com/press-releases/detail/494/ekso-bionicstm-secures-second-phase-of-u-s-special

Also, look at some information in a press release from RESquared Robotics involving Ekso Bionics in the context of wider military application

"The goal of the Phase II effort is to develop a simulation tool capable of producing validated biomechanical data on muscle forces, stresses, joint loads, and metabolic load that a human subject would have produced during load carriage with and without the use of a robotic exoskeleton. This data will help the Army analyze the benefits of exoskeletons and develop injury predictions.

“By directly modeling the interaction between a human user and the exoskeleton, our simulator will help to identify potential injury mechanisms and issues before any large-scale deployment of the device – ultimately reducing injuries while saving the Army time and money,” stated Jorgen Pedersen, president and CEO for RE2.

RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics™ (OTCBB: EKSO), neuromusculoskeletal simulation leader, Dr. Scott Delp and Dr. Jennifer Hicks, faculty at Stanford University, and the Human Engineering Research Laboratories at the University of Pittsburgh to design and test the Biomechanical Exoskeleton Simulator System."

http://www.resquared.com/re2-robotics-exo-simulator/

Disclaimer:

I hold EKSO long
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News